The demonstration of both activated pathways, even in the absence of signs of TMA, could enhance the hypothesis that the complement activation and vWF/ADAMTS13 axis both contribute to the pathogenesis of COVID-19 coagulopathy. The gene discussed is ADAMTS13; the disease is blood coagulation disease.